Cardiothoracics

Question 8 (Sept 2019)

This question regards cardioplegia solution

a) Name 3 reasons cardioplegia is used in cardiac surgery? (3 marks)

b) What is the typical composition of cardioplegia solution? (4 marks)

c) Name 5 physiological effects of cardioplegia solution on the myocardium? (5 marks)

d) Name 2 routes by cardioplegia solution be administered? (2 marks)

e) Name 6 possible complications of cardioplegia solution administration? (6 marks)

Question 8 (March 2019)

 

a) Describe three ways a patient with dilated cardiomyopathy (DCM) could present (3 marks)
 

b) Name 3 pharmacological management options for a patient with DCM (3 marks)

c) Name 2 non-pharmacological management options for a patient with DCM (2 marks)

d) List 2 predictors of poor outcome in patients with DCM undergoing surgery (2 marks)

e) What are the haemodynamic goals when anaesthetising patients with DCM (4 marks)

f) What measures would you take to achieve these haemodynamic goals during anaesthesia (6 marks)

Question 5 (September 2018)

 

a) Name and explain 3 ways to quantify preoperatively risks associated with lung resection (6 marks)

b) Name 6 factors that can lead to the development of high airway pressures during one lung ventilation (OLV) (6 marks)

c) Outline how you would manage the development of hypoxaemia during OLV (8 marks)

Question 3 (March 2018)

 

a) List 5 possible indications for the insertion of cardiac implantalbe electronic devices (5 marks)

b) What 5 factors would you check preoperatively in a patient with these types of devices? (5 marks)

c) Outline 6 relevant pieroperative mangement considerations of a patient with an automatc implantable cardioversion defibrillator who is having elective surgery under general anaesthetic (6 marks)

d) A patient with a pacemaker develops severe bradycardia with circulatory compromiseand no pacemaker response. What 4 specific therapies should you consider in this situation? (4 marks)